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Drs. Hillard and Graham have provided thoughtful comments on our article,1 and we agree 
that we might have underestimated the projected incidence of stomach cancer. As they note, 
the results of our analyses were limited to the 2 major racial groups in the United States 
(blacks and whites) and did not include predictions of the cancer burden for other racial and 
ethnic groups. The age-period-cohort models that we used require a minimum of 20 years of 
incidence data to generate reasonable estimates for predicting future trends in cancer 
incidence.2 The data for these models came from 9 Surveillance, Epidemiology, and End 
Results (SEER) population-based cancer registries, which cover approximately 10% of the 
US population.3 In more recent years, both SEER registries and those participating in the 
Centers for Disease Control and Prevention’s National Program of Cancer Registries have 
been collecting more detailed information regarding race, including Asian/Pacific Islander 
subpopulations and ethnicity (Hispanic and non-Hispanic).4 In addition, cancer registries are 
now in all 50 states and the District of Columbia.4 In the future, with expanded population 
coverage and more detailed information concerning race and ethnicity, it will be possible to 
predict the cancer incidence burden for Asian/Pacific Islander and Hispanic individuals and 
thus improve the projections for cancers that disproportionately impact these populations.
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